CLRB - Cellectar stock climbs 8% on results for CNS malignancy therapy
2024-01-22 12:47:02 ET
More on Cellectar Biosciences
- Cellectar Biosciences, Inc. (CLRB) Q3 2023 Earnings Call Transcript
- Cellectar Biosciences gains on pivotal data for radiotherapy
- Seeking Alpha’s Quant Rating on Cellectar Biosciences
- Historical earnings data for Cellectar Biosciences
- Financial information for Cellectar Biosciences